IRIS
PRIORI, SILVIA GIULIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.378
EU - Europa 8.439
AS - Asia 5.736
AF - Africa 57
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 15
SA - Sud America 10
Totale 25.653
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.315
CN - Cina 5.614
IE - Irlanda 2.593
UA - Ucraina 1.665
DE - Germania 879
IT - Italia 876
FI - Finlandia 856
SE - Svezia 740
GB - Regno Unito 438
FR - Francia 231
CA - Canada 62
RU - Federazione Russa 49
MU - Mauritius 40
IN - India 30
NL - Olanda 28
IR - Iran 24
BE - Belgio 19
AU - Australia 16
EU - Europa 13
JP - Giappone 13
PT - Portogallo 13
ES - Italia 12
ID - Indonesia 12
CH - Svizzera 11
SK - Slovacchia (Repubblica Slovacca) 9
EG - Egitto 7
IL - Israele 7
HK - Hong Kong 6
KR - Corea 6
CL - Cile 5
GR - Grecia 5
PL - Polonia 5
AT - Austria 4
MY - Malesia 4
TW - Taiwan 4
BR - Brasile 3
PH - Filippine 3
TR - Turchia 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
IQ - Iraq 2
NZ - Nuova Zelanda 2
SG - Singapore 2
SO - Somalia 2
TN - Tunisia 2
VN - Vietnam 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
LV - Lettonia 1
MT - Malta 1
SI - Slovenia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 25.653
Salva come PNG Salva come JPEG
Città #
Dublin 2.591
Chandler 2.494
Jacksonville 2.150
Nanjing 1.723
Ashburn 829
Nanchang 740
Princeton 651
Lawrence 586
Wilmington 540
Hebei 530
Changsha 478
Shenyang 452
Jiaxing 375
Medford 375
Beijing 317
Tianjin 300
Helsinki 275
San Genesio Ed Uniti 257
Boardman 253
Hangzhou 238
Woodbridge 197
Milan 149
Ann Arbor 125
Shanghai 122
Norwalk 107
Verona 107
Falls Church 93
New York 82
Seattle 68
Des Moines 55
Fairfield 49
Houston 47
Toronto 47
Kunming 43
Los Angeles 43
Washington 36
Jinan 32
Ningbo 29
Tappahannock 29
Zhengzhou 29
Dearborn 28
Pavia 25
Rome 24
Taizhou 20
Changchun 18
Guangzhou 18
Brussels 16
Missoula 15
Pune 14
Lanzhou 13
Mykolayiv 12
Orange 12
Palermo 12
Auburn Hills 11
Borås 11
London 9
Piscataway 8
Saint Petersburg 8
Madrid 7
Semarang 7
Zanjan 7
Fuzhou 6
Novokuznetsk 6
Redwood City 6
San Francisco 6
Tehran 6
Aduard 5
Kobe 5
Melbourne 5
Novara 5
Phoenix 5
Somma Lombardo 5
Tavira 5
Turin 5
Zola Predosa 5
Alghero 4
Bastia umbra 4
Berlin 4
Brisbane 4
Cambridge 4
Kishangarh 4
Kraków 4
Las Vegas 4
Leeds 4
Legnaro 4
Monmouth Junction 4
Mountain View 4
Padova 4
Redmond 4
Rockville 4
Sydney 4
Taipei 4
Weinan 4
Atlanta 3
Barreiro 3
Cairo 3
Chicago 3
Columbus 3
Como 3
Falkenstein 3
Totale 18.106
Salva come PNG Salva come JPEG
Nome #
Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology; ESC Committee for Practice Guidelines (CPG). Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology 139
Calcio antagonisti e aritmie da riperfusione miocardica 131
Tachicardia Ventricolare Polimorfa Catecolaminergica 127
From decision to shared-decision: Introducing patients' preferences into clinical decision analysis. 114
American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents; European Society of Cardiology Committee for Practice Guidelines. American college of cardiology/european society of cardiology clinical expert consensus documen on hypertrophic cardiomyopathy. A report of the american college of cardiology foundation task force on clinical expert consensus documents and the european society of cardiology committee for practice guidelines 93
Aspetti elettrofisiologici della modulazione dei canali del potassio ATP-dipendenti 84
Task Force. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. 78
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 77
Task Force on Syncope, European Society of Cardiology.Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary. 76
Gene-specific therapy for inherited arrhythmogenic diseases 74
Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol: Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology 74
Spotlight on sudden cardiac death 73
Computer simulation of wild-type and mutant human cardiac Na+ current 73
Images in cardiovascular medicine. Endocardial implantation of a cardioverter-defibrillator in a 13-month-old child affected by long-QT syndrome and syndactyly. 72
2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on practice guidelines. American College of Cardiology Foundation/American Heart Association Task Force. 72
Risk stratification in the Long-QT Syndrome 71
European Society of Cardiology. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. 69
A common polymorphism associated with antibiotic-induced cardiac arrhythmia 69
FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. 68
Linee Guida. Task Force sulla Morte Cardiaca Improvvisa, Società Europea di Cardiologia. Riassunto delle raccomandazioni 67
Long QT syndrome and catecholaminergic VT 67
A cardiac arrhythmia syndrome caused by loss of ankyrin-B function 67
Arrhythmogenic mechanisms in a mouse model of Catecholaminergic Polymorphic Ventricular Tachycardia. 67
Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome 66
Abnormal Calcium Signalling and Sudden Cardiac Death Associated With Mutation of Calsequestrin. 66
Catecholaminergic Polymorphic Ventricular Tachycardia. 66
Universal definition of the myocardial infarction 66
Inherited arrhythmogenic diseases 66
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk 66
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias-executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) Developed in Collaboration with NASPE-Heart Rhythm Society 65
Task Force on Clinical Expert Consensus Documents. American College of Cardiology; Committee for Practice Guidelines. European Society of Cardiology. American college of cardiology/european society of cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the american college of cardiology foundation task force on clinical expert consensus documents and the european society of cardiology committee for practice guidelines 65
Inherited arrhythmia: present and future perspectives for genetic therapy 65
La Sindrome di Brugada: aspetti clinici, criteri diagnostici, stratificazione prognostica. 65
Adrenergic Arrhythmogenesis and The Long QT syndrome 65
Idiopathic Ventricular Fibrillation. 65
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents 65
Policy statement: ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe. 64
Guidelines On Diabetes, Pre-Diabetes, And Cardiovascular Diseases: Executive Summary.The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). 64
Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary 64
Cost-effectiveness of Neonatal ECG as a Screening for Long QT-syndrome: A Decision Analysis Approach. 63
Cardiac Sodium Channel Diseases 63
Proposed Diagnostic Criteria for the Brugada Syndrome. 63
A method of gene transfer for the treatment of recessive CPVT 63
Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease 63
Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. 62
Yield of Genetic Screening in Inherited Cardiac Channelopathies. 62
Acute oral drug testing in the evaluation of a new antiarrhythmic agent: Penticainide (CM 7857) 62
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC 62
Clinical profile and genetic basis of Brugada syndrome in the Chinese population. 61
Task Force Members; ESC Committee for Practice Guidelines (CPG); Document Reviewers. Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology 61
Molecular underpinning of ''good luck'' 61
Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. 61
Ryanodine receptor and calsequestrin in arrhythmogenesis: What we have learnt from genetic diseases and transgenic mice 61
SUDDEN CARDIAC DEATH 61
Gender-specific prescription for cardiovascular diseases? 60
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society 60
Clinical and Molecular Characterization of Patients with Catecholominergic Polymorphic Ventricular Tachycardia. 60
“Cardiac Risk Stratification by NOS1AP Genotyping” 60
The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases 60
Drug-induced torsades de pointes and implications for drug development. 60
Clinical presentation and outcome of Brugada syndrome diagnosed with the new 2013 criteria 60
From genes to cell therapy: molecular medicine meets clinical EP 59
Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. 59
Update of the guidelines on sudden cardiac death of the European Society of Cardiology 59
Progress in the evaluation of a new class I antiarrhythmic agent: Penticainide 59
Gene specific therapy for cardiac disease: the case of long QT Sydnrome 59
ST-Segment Elevation in the Setting of a Febrile Illness. 59
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry 59
Increased Ca2+ Sensitivity of the Ryanodine Receptor Mutant RyR2R4496C Underlies Catecholaminergic Polymorphic Ventricular Tachycardia. 59
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC 59
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac Death. The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology] 59
Beyond Cohort Selection: An Analytics-Enabled i2b2 59
A newly charactarized SCN5A mutation underlying Brugada Syndrome unmasked by Hyperthermia 59
Catecholaminergic Polymorphic Ventricular Tachycardia, Recurrent Syncope, and Implantable Loop Recorder 58
Evaluation of BLS-D training in lay people. 58
R Engine Cell: integrating R into the i2b2 software infrastructure. 58
2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association 58
Lack of correlation between occlusion and reperfusion arrhythmias in the cat. 58
Identificazione delle mutazioni intrageniche 58
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). 58
Gene therapy to treat cardiac arrhythmias 58
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society 57
Modulating effects of age and gender on the clinical course of long QT syndrome by genotype 57
Multiple comparison of several antiarrhythmic agents by acute oral drug testing in patients with chronic ventricular arrhythmias 57
Basi genetiche della morte cardiaca improvvisa 57
L-TYPE CALCIUM CHANNEL DISEASE 57
La Sindrome di Brugada 57
A novel SCN5A mutation associated with long QT-3: altered inactivation kinetics and channel dysfunction 57
Genetic determinants of cardiac (electric) conduction. 57
Guidelines in cardiac pacing and resynchronization therapy. 57
Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (RYR2). 57
Postmortem molecular analysis in victims of sudden unexplained death 57
Information extraction from Italian medical reports: An ontology-driven approach 57
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 57
Inherited arrhythmia syndromes: applying the molecular biology and genetic to the clinical management. 56
Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. 56
Long QT Syndrome 56
Is Long QT syndrome entering the era of molecular diagnosis ? 56
Clinical utility gene card for: Catecholaminergic polymorphic ventricular tachycardia (CPVT). 56
Novel Arrhythmogenic mechanism revealed by Long-QT Syndrome mutation in the Cardiac NA+ Channel 56
Totale 6.543
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.840
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201939 0 0 0 0 0 0 0 0 0 0 7 32
2019/20206.656 2.111 2.802 7 305 8 337 22 389 26 440 202 7
2020/20213.187 357 304 102 307 4 415 18 489 183 475 420 113
2021/20222.393 18 6 64 22 53 124 61 138 183 113 372 1.239
2022/20237.411 879 426 86 632 730 835 7 379 3.047 34 229 127
2023/20242.605 308 512 113 276 291 700 128 156 17 84 20 0
Totale 26.039